Germany has decided to approve the Oxford/AstraZeneca Covid-19 jab for people aged 65 and over, in a move that could help speed up the country’s sluggish vaccination campaign.
Germany’s standing commission on vaccinations, known as Stiko, had previously recommended the vaccine only be used on those aged 18 to 64, arguing that there was a lack of evidence from clinical trials showing its effectiveness in older people.
It made the decision despite the fact that the European Medicines Agency approved its use in all adults.
您已閱讀30%（523字），剩余70%（1218字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。